Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trifarotene + Doxycycline in Severe Acne Vulgaris
NCT04451330Phase 4Completed
- Sponsor
- Galderma
- Start
- Jul 2020
- Primary completion
- Apr 2021
- Countries
- 2
01
Overview
A Phase 4 trial of CD5789 cream vehicle in acne vulgaris, sponsored by Galderma. Started Jul 2020; status: completed.
02
Drugs
CD5789 cream vehicle
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04451330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04451330.